990x120-1

Halting the Tuberculosis Epidemic with Research and Diagnostics: A Conversation with David Alland
Welcome to The Scientist’s LabTalk, a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research.

This episode is brought to you by Keystone Symposia. Don’t miss their upcoming virtual eSymposia Tuberculosis: Science Aimed at Ending the Epidemic on December 2-4, 2020.

One of the eSymposia’s co-organizers and keynote speaker is David Alland, Chief of Infectious Disease and Director of the Center for Emerging Pathogens and the Center for COVID-19 Response and Pandemic Preparedness at Rutgers New Jersey Medical School. Niki Spahich from The Scientist’s Creative Services team spoke with Alland about his journey to develop a rapid, point-of-care tuberculosis diagnostic and his current research on mutations that lead to drug resistance.
EK10-banner-tuberculosis-1200x400 (1) 
 


Speaker
Gatenby.jpg
David Alland, MD, MSc
Chief of Infectious Disease
Director of the Center for Emerging Pathogens
Director of the Center for COVID-19 Response and Pandemic Preparedness
Rutgers New Jersey Medical School

Listen Now

Podcast

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.

The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@labxmediagroup.com

Privacy Policy

© 1986-2019The Scientist

 

 
 
The Scientist Logo_white